Vimarsana
Biggest News Aggregation in the World

Aaron Royston News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aaron Royston. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aaron Royston Today - Breaking & Trending Today

RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors - Vimarsana News

RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors

01.11.2023 - SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) - RayzeBio, Inc. (Nasdaq: RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the appointment of Tim Van Hauwermeiren to ... Seite 1

Attovia Therapeutics Raises $60M in Series A Financing - Vimarsana News

Attovia Therapeutics Raises $60M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Attovia, a new California biotech, launches with plans to rethink how drugs bind their targets - Vimarsana News

Attovia, a new California biotech, launches with plans to rethink how drugs bind their targets

BioPharma

Ceptur Therapeutics Raises $75M in Series A Financing - Vimarsana News

Ceptur Therapeutics Raises $75M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market - Vimarsana News

Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market

/PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze"), a clinical-stage pharmaceutical company focused on the development and commercialization of innovative...